Shvidel, L <br/><br/>
Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma.  [electronic resource] 

 -  American journal of hematology  Jul 2001 
 - 213-4 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>0361-8609 
<br/><br/><label>Standard No.: </label>10.1002/ajh.1112  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Gland Neoplasms<br/>Adult<br/>Alkylating Agents--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antigens, CD20--immunology<br/>Combined Modality Therapy<br/>Drug Resistance<br/>Humans<br/>Immunization, Passive<br/>Immunoglobulin G--blood<br/>Immunosuppressive Agents--therapeutic use<br/>Immunotherapy<br/>Lymphoma, B-Cell--blood<br/>Lymphoma, Non-Hodgkin--blood<br/>Male<br/>Neoplasm Proteins--blood<br/>Neoplasms, Multiple Primary<br/>Pheochromocytoma<br/>Purpura--etiology<br/>Purpura, Thrombocytopenic, Idiopathic--drug therapy<br/>Remission Induction<br/>Rituximab<br/>Splenectomy